Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind study of M605106 in axillary osmidrosis
jRCT2031200184Phase 2Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of M605106 in axillary bromhidrosis, sponsored by Maruho Co., Ltd. Primary endpoint: axillary odor scores. Started Oct 2020; status: completed.
02
Drugs
M605106
03
Conditions
axillary bromhidrosis
Beyond the preview
Go deeper on jRCT2031200184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200184.